Hong Weng

6PUBLICATIONS
25CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 30, 2026
GSTM4 Suppresses Prostate Cancer Progression by Targeting TRIM27-mediated ACLY Ubiquitination and Lipid Metabolism.

|Feb 13, 2026
LDHB Deficiency in Fibroblasts Induces Lactate-Mediated Inflammatory Reprogramming That Promotes Breast Cancer Metastasis.

Zhihong Luo, Kangdi Li, You Yu

|Oct 28, 2025
YTHDC2 suppresses bladder cancer by inhibiting SOX2-mediated tumor plasticity.

Yi Cai, Cong Zhu, Ming-Hui Shi

|Oct 23, 2025
A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression.

Shuai Yuan, Dao-Jing Ming, Jiapeng He

|Feb 20, 2021
STAT1 is a key gene in a gene regulatory network related to immune phenotypes in bladder cancer: An integrative analysis of multi-omics data.

Hong Weng, Shuai Yuan, Qiao Huang

|Jan 15, 2020
Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.

Wu-Wen Zhang, Xin-Liang Ming, Yuan Rong

Pageof 1

Frequent Collaborators

4 joint publications

Xian-Tao Zeng

2 joint publications

Xing-Huan Wang

2 joint publications

Shuai Yuan

1 joint publications

Wu-Wen Zhang